Purdue Pharma, in a 2017 patent proceeding: states that Dr. Curtis Wright, the FDA medical officer who reviewed OxyContin, joined Purdue in 1998 as Executive Director of Medical Research. Purdue's own statement.
A critical point in the development was in 1998, when Dr. Curtis Wright joined Purdue as Executive Director of Medical Research.
PDF p. 22 (printed p. 6)
Purdue Pharma, in a 2017 patent proceeding: states that Dr. Curtis Wright, the FDA medical officer who reviewed OxyContin, joined Purdue in 1998 as Executive Director of Medical Research. Purdue's own statement.